Literature DB >> 14678990

Integrin alpha1beta1 and alpha2beta1 are the key regulators of hepatocarcinoma cell invasion across the fibrotic matrix microenvironment.

Changqing Yang1, Michael Zeisberg, Julie C Lively, Pia Nyberg, Nezam Afdhal, Raghu Kalluri.   

Abstract

As with many types of cancer, cell motility is an important factor in the progression and metastasis of hepatocellular carcinomas (HCC). HCC is associated with significant fibrosis in the liver. The fibrotic microenvironment in the liver is characterized by an altered composition of the extracellular matrix (ECM) and an abundance of growth factors that are likely conducive to migration of HCC cells. The purpose of this study was to delineate promigratory stimuli within the fibrotic microenvironment and to identify specific targets for prevention of HCC cell migration. We used a modified Boyden chamber system that allowed distinction between chemotactic (indirect stimulation) and haptotactic (direct stimulation) migration of two distinct HCC cell lines across the ECM-coated membrane. Fibrotic microenvironment-associated growth factors, such as transforming growth factor beta1 (TGF-beta1), basic fibroblast growth factor (bFGF), and epidermal growth factor (EGF), induced chemotactic and haptotactic migration of HepG2 and Chang cells. Neutralizing antibodies to individual growth factors significantly decreased chemotactic and haptotactic migration. Haptotactic stimulation, but not chemotactic stimulation of HCC cell lines with TGF-beta1, bFGF, and EGF, induced production of matrix metalloproteinase (MMP) 2, a potential mediator of migration. Inhibition of MMPs significantly decreased haptotactic migration induced by individual growth factors but had an insignificant effect on chemotactic migration, suggesting an MMP-independent migration in this setting. Inhibition of cell-ECM interactions with blocking antibodies to alpha1 and alpha2 integrins were sufficient to inhibit both haptotactic and chemotactic migration induced by individual growth factors, strongly suggesting that targeting these integrins to abrogate pathogenic cell-ECM interactions might be a promising tool for inhibiting growth factor-induced invasion and metastasis of HCC.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14678990

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  51 in total

1.  A 3D matrix platform for the rapid generation of therapeutic anti-human carcinoma monoclonal antibodies.

Authors:  David T Dudley; Xiao-Yan Li; Casey Y Hu; Celina G Kleer; Amanda L Willis; Stephen J Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-29       Impact factor: 11.205

2.  Angiopoietin-like protein 1 suppresses SLUG to inhibit cancer cell motility.

Authors:  Tsang-Chih Kuo; Ching-Ting Tan; Yi-Wen Chang; Chih-Chen Hong; Wei-Jiunn Lee; Min-Wei Chen; Yung-Ming Jeng; Jean Chiou; Pei Yu; Pai-Sheng Chen; Ming-Yang Wang; Michael Hsiao; Jen-Liang Su; Min-Liang Kuo
Journal:  J Clin Invest       Date:  2013-02-22       Impact factor: 14.808

3.  TSC2 modulates cell adhesion and migration via integrin-α1β1.

Authors:  Lyn M Moir; Judith L Black; Vera P Krymskaya
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-08-24       Impact factor: 5.464

4.  C-reactive protein binds to integrin α2 and Fcγ receptor I, leading to breast cell adhesion and breast cancer progression.

Authors:  E-S Kim; S Y Kim; M Koh; H-M Lee; K Kim; J Jung; H S Kim; W K Moon; S Hwang; A Moon
Journal:  Oncogene       Date:  2017-08-28       Impact factor: 9.867

Review 5.  Integrins in cancer: biological implications and therapeutic opportunities.

Authors:  Jay S Desgrosellier; David A Cheresh
Journal:  Nat Rev Cancer       Date:  2010-01       Impact factor: 60.716

6.  Basement membrane proteins play an active role in the invasive process of human hepatocellular carcinoma cells with high metastasis potential.

Authors:  Bo Tian; Yan Li; Xue-Ning Ji; Jie Chen; Qiong Xue; Sheng-Long Ye; Yin-Kun Liu; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2004-10-12       Impact factor: 4.553

7.  Integrins as antimetastatic targets of RGD-independent snake venom components in liver metastasis [corrected].

Authors:  Felix Rosenow; Rainer Ossig; Dorit Thormeyer; Peter Gasmann; Kerstin Schlüter; Georg Brunner; Jörg Haier; Johannes A Eble
Journal:  Neoplasia       Date:  2008-02       Impact factor: 5.715

Review 8.  Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma.

Authors:  Virginia Hernandez-Gea; Sara Toffanin; Scott L Friedman; Josep M Llovet
Journal:  Gastroenterology       Date:  2013-01-09       Impact factor: 22.682

9.  The role of integrins in cancer and the development of anti-integrin therapeutic agents for cancer therapy.

Authors:  Xinjie Lu; Dong Lu; Mike Scully; Vijay Kakkar
Journal:  Perspect Medicin Chem       Date:  2008-04-10

10.  Characteristic gene expression profiles in the progression from liver cirrhosis to carcinoma induced by diethylnitrosamine in a rat model.

Authors:  Yue-Fang Liu; Bin-Shan Zha; Hui-Lin Zhang; Xiao-Jing Zhu; Yu-Hua Li; Jin Zhu; Xiao-Hong Guan; Zhen-Qing Feng; Jian-Ping Zhang
Journal:  J Exp Clin Cancer Res       Date:  2009-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.